We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+21.92%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.44B
AUM Growth
+$302M
Cap. Flow
+$9.92M
Cap. Flow %
0.69%
Top 10 Hldgs %
50.32%
Holding
229
New
57
Increased
37
Reduced
31
Closed
55
Avg Time Held Equity + Options
2.9 quarters
Top 10 Avg Time Held Equity + Options
4.7 quarters
Top 20 Avg Time Held Equity + Options
4.1 quarters
Avg Time Held Equity only
3.1 quarters
Top 10 Avg Time Held Equity only
4.7 quarters
Top 20 Avg Time Held Equity only
4.9 quarters

Top Buys

Rank Stock Value
1
NXTM
NxStage Medical Inc.
NXTM
+$24.7M
2
MDVN
MEDIVATION, INC.
MDVN
+$23.8M
3
GBT
Global Blood Therapeutics, Inc.
GBT
+$18.4M
4
STJ
St Jude Medical
STJ
+$16.6M
5
LJPC
La Jolla Pharmaceutical Company
LJPC
+$11.4M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$41.5M
2
HUM icon
Humana
HUM
+$20.1M
3
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$12.4M
4
BAX icon
Baxter International
BAX
+$9.04M
5
XLRN
Acceleron Pharma
XLRN
+$6.5M

Sector Composition

Rank Sector Weight
1 Healthcare 78.68%
2 Miscellaneous 20.64%
3 Consumer Staples 0.52%
4 Consumer Discretionary 0.08%
5 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NVTA
201
DELISTED
Invitae Corporation
NVTA
– –
-118,366
Closed -$1.21M –
MRTX
202
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-273,000
Closed -$5.84M –
SYNH
203
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-11,846
Closed -$488K –
INFI
204
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-100,000
Closed -$527K –
OTIC
205
DELISTED
Otonomy, Inc.
OTIC
– –
-235,986
Closed -$3.52M –
GTS
206
DELISTED
Triple-S Management Corporation
GTS
– –
-11,147
Closed -$264K –
DRNA
207
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-50,000
Closed -$268K –
TRIL
208
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-30,000
Closed -$278K –
PRAH
209
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-11,751
Closed -$502K –
GWPH
210
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-13,109
Closed -$946K –
MNK
211
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-2,673
Closed -$164K –
AGN
212
DELISTED
Allergan plc
AGN
– –
-155,000
Closed -$41.5M –
ALDR
213
PUT
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-200,000
Closed -$4.9M –
HZNP
214
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-350,000
Closed -$5.8M –
AKAO
215
DELISTED
Achaogen Inc
AKAO
– –
-60,000
Closed -$166K –
ELGX
216
DELISTED
Endologix Inc
ELGX
– –
-2,500
Closed -$209K –
PMC
217
DELISTED
PharMerica Corporation
PMC
– –
-16,841
Closed -$372K –
SPNC
218
DELISTED
Spectranetics Corp
SPNC
– –
-267,070
Closed -$3.88M –
GI
219
DELISTED
EndoChoice Holdings, Inc.
GI
– –
-25,000
Closed -$130K –
NSPH
220
DELISTED
NANOSPHERE INC. COM NEW
NSPH
– –
-35,379
Closed -$28K –
CELG
221
DELISTED
Celgene Corp
CELG
– –
-50,000
Closed -$5M –
VXX icon
222
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
– –
-3,750
Closed -$1.06M –
5 6 7 8
9

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Perceptive Advisors held 229 positions worth $1.44B, up 27% from $1.14B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors's Q2 2016 filing shows 57 new, 37 increased, 31 reduced and 55 closed positions. Its largest new stake was NxStage Medical Inc.: 1,382,410 shares worth $30M. The largest sale was Allergan plc, an estimated $41.5M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 93% a quarter earlier, followed by Miscellaneous and Consumer Staples.

  • Perceptive Advisors's largest Q2 2016 buy was NxStage Medical Inc.: 1,382,410 shares worth $30M.
  • Perceptive Advisors added most to MEDIVATION, INC. in Q2 2016, an estimated $23.8M increase.
  • Perceptive Advisors's biggest Q2 2016 reduction was Five Prime Therapeutics, Inc., cutting an estimated $12.4M.
  • Perceptive Advisors fully exited Allergan plc in Q2 2016, selling an estimated $41.5M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.44B portfolio in Q2 2016.
  • Perceptive Advisors opened 57 new positions and closed 55 in Q2 2016.
  • Perceptive Advisors's portfolio value rose 27% quarter-over-quarter to $1.44B.

Based on Perceptive Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.